Pharma News

renewable energy related M&A activity in the pharmaceutical industry

In value terms, renewable energy-related deal activity decreased by % in Q4 2023 compared with the previous quarter’s total of 0. Related deal volume remained flat in Q4 2023 versus the previous quarter and was 100% higher than in Q4 2022.

The top-ranked financial advisors supporting these M&A deals in Q4 2023 were Bloom Burton Securities; Morgan Stanley; Raymond James Financial with 1, 1, 1 deals respectively.

The top-ranked legal advisors supporting these M&A deals in Q4 2023 were Blake, Cassels & Graydon; Faus & Moliner Solicitors; Norton Rose Fulbright with 1, 1, 1 deals respectively.

For further understanding of GlobalData’s Pharmaceuticals Industry M&A Deals by Top Themes in 2023 – Thematic Intelligence, buy the report here.

Access the most comprehensive Company Profiles
on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free
sample

Your download email will arrive shortly

We are confident about the
unique
quality of our Company Profiles. However, we want you to make the most
beneficial
decision for your business, so we offer a free sample that you can download by
submitting the below form

By GlobalData

This content was updated on 24 January 2008




Source link
#renewable #energy #related #activity #pharmaceutical #industry

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *